BEAT HeartBeam Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BEAT

Price (delayed)

$1.96

Market cap

$66.1M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.73

Enterprise value

$63.72M

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing ...

Highlights
The equity has dropped by 90% year-on-year and by 66% since the previous quarter
BEAT's quick ratio has dropped by 89% year-on-year and by 53% since the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: https://www.heartbeam.com
Peers: TDOC VEEV OMCL HSTM

Key stats

What are the main financial stats of BEAT
Market
Shares outstanding
33.73M
Market cap
$66.1M
Enterprise value
$63.72M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
31.6
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$19.89M
Net income
-$19.45M
EBIT
-$19.45M
EBITDA
-$19.44M
Free cash flow
-$14.67M
Per share
EPS
-$0.73
EPS diluted
-$0.73
Free cash flow per share
-$0.55
Book value per share
$0.06
Revenue per share
$0
TBVPS
$0.12
Balance sheet
Total assets
$3.28M
Total liabilities
$1.62M
Debt
$0
Equity
$1.65M
Working capital
$1.15M
Liquidity
Debt to equity
0
Current ratio
1.71
Quick ratio
1.47
Net debt/EBITDA
0.12
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-230.9%
Return on equity
-280.8%
Return on invested capital
N/A
Return on capital employed
-1,175.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BEAT stock price

How has the HeartBeam stock price performed over time
Intraday
-2%
1 week
1.03%
1 month
-2.97%
1 year
-6.22%
YTD
-14.78%
QTD
-2.49%

Financial performance

How have HeartBeam's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$19.89M
Net income
-$19.45M
Gross margin
N/A
Net margin
N/A
BEAT's net income is down by 33% year-on-year and by 6% since the previous quarter
The operating income has contracted by 30% YoY and by 4.4% from the previous quarter

Growth

What is HeartBeam's growth rate over time

Valuation

What is HeartBeam stock price valuation
P/E
N/A
P/B
31.6
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
BEAT's EPS is down by 7% from the previous quarter
The price to book (P/B) is 107% higher than the last 4 quarters average of 15.6
The equity has dropped by 90% year-on-year and by 66% since the previous quarter

Efficiency

How efficient is HeartBeam business performance
HeartBeam's return on equity has shrunk by 163% YoY and by 60% QoQ
The company's return on assets has shrunk by 136% YoY and by 49% QoQ

Dividends

What is BEAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BEAT.

Financial health

How did HeartBeam financials performed over time
HeartBeam's total assets is 102% higher than its total liabilities
BEAT's quick ratio has dropped by 89% year-on-year and by 53% since the previous quarter
The current ratio has shrunk by 88% YoY and by 48% QoQ
HeartBeam's debt is 100% less than its equity
The equity has dropped by 90% year-on-year and by 66% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.